BioLife Solutions, Inc.

NasdaqCM:BLFS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

📦 Containers & Packaging

🚚 Logistics & Freight

🩺 Medical Instruments

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 1.01 B

Share Price

USD 21.09

Avg Daily Volume

542,814

Change (1 day)

1.74%

Change (1 year)

-7.82%

Change (YTD)

-18.76%

BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -17.56%

BioLife Solutions, Inc. EBITDA Margin is -17.56% for the Trailing 12 Months (TTM) ending September 30, 2024, a -43.23% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -30.93%, a -48.26% change year over year.
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -59.79%, a 261.87% change year over year.
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -16.52%, a -37.57% change year over year.
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -26.47%, a -330.11% change year over year.